Effect of 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB-153) on hepatocyte proliferation and apoptosis in mice deficient in the p50 subunit of the transcription factor NF-κB

Toxicological Sciences

Volumn 81, Issue 1, 2004, Pages 35-42

  Lu, Zijing ^c   Lee, Eun Y ^b,c   Robertson, Larry W ^a,c   Glauert, Howard P ^c   Spear, Brett T ^b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Apoptosis; Cell proliferation; Hepatocytes; NF B; PCBs

Indexed keywords

2,2',4,4',5,5' HEXACHLOROBIPHENYL; CORN OIL; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN D2; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P50; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; RIBONUCLEASE PROTECTION ASSAY; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BODY WEIGHT; BROMODEOXYURIDINE; CELL NUCLEUS; CELL PROLIFERATION; CYCLINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER; MALE; MICE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NUCLEASE PROTECTION ASSAYS; ORGAN SIZE; POLYCHLORINATED BIPHENYLS; RNA, MESSENGER;

RODENTIA; ZEA MAYS;

EID: 4444297823     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh193     Document Type: Article

References (47)

1. Albrecht, J. H., Hu, M. Y., and Cerra, F. B. (1995). Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem. Biophys. Res. Commun. 209, 648-55.
2. Awad, M. M., and Gruppuso, P. A. (2000). Cell cycle control during liver development in the rat: Evidence indicating a role for cyclin D1 posttranscriptional regulation. Cell Growth Differ. 11, 325-334.
3. Bandiera, S., Safe, S., and Okey, A. B. (1982). Binding of polychlorinated biphenyls classified as either phenobarbitone-, 3-methylcholanthrene- or mixed-type inducers to cytosolic Ah receptor. Chem. Biol. Interact. 39, 259-77.
4. Bartek, J., Bartkova, J., and Lukas, J. (1996). The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8, 805-814.
5. Beg, A., Sha, W., Bronson, R., Ghosh, S., and Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167-170.
6. Beijersbergen, R. L., and Bernards, R. (1996). Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta 1287, 103-120.
7. Biswas, D. K., Cruz, A. P., Gansberger, E., and Pardee, A. B. (2000). Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 97, 8542-8547.
8. Bohnenberger, S., Wagner, B., Schmitz, H. J., and Schrenk, D. (2001). Inhibition of apoptosis in rat hepatocytes treated with 'non-dioxin-like' polychlorinated biphenyls. Carcinogenesis 22, 1601-1606.
9. DeAngelis, R. A., Kovalovich, K., Cressman, D. E., and Taub, R. (2001). Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice. Hepatology 33, 915-924.
10. Denomme, M. A., Bandiera, S., Lambert, I., Copp, L., Safe, L., and Safe, S. (1983). Polychlorinated biphenyls as phenobarbitone-type inducers of microsomal enzymes. Structure-activity relationships for a series of 2,4-dichlorosubstituted congeners. Biochem. Pharmacol. 32, 2955-2963.
11. Deryckere, F., and Gannon, F. (1994). A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16, 405.
12. Glauert, H. P., Robertson, L. W., and Silberhorn, E. M. (2001). PCBs and tumor promotion. In PCBs: Recent Advances in Environmental Toxicology and Health Effects (L. W. Robertson, and L. G. Hansen, Eds.), pp. 355-371. University Press of Kentucky, Lexington, KY.
13. Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., and Baldwin, A. S., Jr. (1999). NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19, 5785-5799.
14. Haag-Gronlund, M., Conolly, R., Scheu, G., Warngard, L., and Fransson-Steen, R. (2000). Analysis of rat liver foci growth with a quantitative two-cell model after treatment with 2,4,5,3′,4′-pentachlorobiphenyl. Toxicol. Sci. 57, 32-42.
15. Henry, D. O., Moskalenko, S. A., Kaur, K. J., Fu, M., Pestell, R. G., Camonis, J. H., and White, M. A. (2000). Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB. Mol. Cell. Biol. 20, 8084-8092.
16. Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., and Strauss, M. (1999). NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 19, 2690-2698.
17. Iimuro, Y., Nishiura, T., Hellerbrand, C., Behrns, K. E., Schoonhoven, R., Grisham, J. W., and Brenner, D. A. (1998). NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101, 802-811.
18. Joyce, D., Bouzahzah, B., Fu, M., Albanese, C., D'Amico, M., Steer, J., Klein, J. U., Lee, R. J., Segall, J. E., Westwick, et al. (1999). Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J. Biol. Chem. 274, 25245-25249.
19. Kaltschmidt, B., Kaltschmidt, C., Hehner, S. P., Droge, W., and Schmitz, M. L. (1999). Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene 18, 3213-3225.
20. Kato, A., Edwards, M. J., and Lentsch, A. B. (2002). Gene deletion of NF-kappa B p50 does not alter the hepatic inflammatory response to ischemia/reperfusion. J. Hepatol. 37, 48-55.
21. Kitamura, T., Watanabe, S., and Sato, N. (1998). Liver regeneration, liver cancers and cyclins. J. Gastroenterol. Hepatol. 13(Suppl), S96-S99.
22. Kolaja, K. L., Engelken, D. T., and Klaassen, C. D. (2000). Inhibition of gap-junctional-intercellular communication in intact rat liver by nongenotoxic hepatocarcinogens. Toxicology 146, 15-22.
23. Lee, H. H., Dadgostar, H., Cheng, Q., Shu, J., and Cheng, G. (1999). NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 96, 9136-9141.
24. Li, X., and Stark, G. R. (2002). NFkappaB-dependent signaling pathways. Exp. Hematol. 30, 285-296.
25. Li, Y., Glauert, H. P., and Spear, B. T. (2000). Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E. Biochem. Pharmacol. 59, 427-434.
26. Li, Y., Leung, L. K., Glauert, H. P., and Spear, B. T. (1996a). Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity. Carcinogenesis 17, 2305-2309.
27. Li, Y., Leung, L. K., Spear, B. T., and Glauert, H. P. (1996b). Activation of hepatic NF-kappaB by phenobarbital in rats. Biochem. Biophys. Res. Commun. 229, 982-989.
28. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996). Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86, 147-157.
29. Lu, Z., Tharappel, J. C., Lee, E. Y., Robertson, L. W., Spear, B. T., and Glauert, H. P. (2003). Effect of a single dose of polychlorinated biphenyls on hepatic cell proliferation and the DNA binding activity of NF-kappaB and AP-1 in rats. Mol. Carcinogen. 37, 171-180.
30. Mayes, B. A., McConnell, E. E., Neal, B. H., Brunner, M. J., Hamilton, S. B., Sullivan, T. M., Peters, A. C., Ryan, M. J., Toft, J. D., Singer, et al. (1998). Comparative carcinogenicity in Sprague-Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260. Toxicol. Sci. 41, 62-76.
31. Nilakantan, V., Spear, B. T., and Glauert, H. P. (1998). Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate. Carcinogenesis 19, 631-637.
32. Parkinson, A., Safe, S. H., Robertson, L. W., Thomas, P. E., Ryan, D. E., Reik, L. M., and Levin, W. (1983). Immunochemical quantitation of cytochrome P-450 isozymes and epoxide hydrolase in liver microsomes from polychlorinated or polybrominated biphenyl-treated rats. A study of structure-activity relationships. J. Biol. Chem. 258, 5967-5976.
33. Robertson, L. W., and Hansen, L. G. (2001). PCBs: Recent Advances in Environmental Toxicology and Health Effects. University Press of Kentucky, Lexington, KY.
34. Safe, S., Bandiera, S., Sawyer, T., Robertson, L., Safe, L., Parkinson, A., Thomas, P. E., Ryan, D. E., Reik, L. M., Levin, W., Denomme, M. A., and Fujita, T. (1985). PCBs: Structure-function relationships and mechanism of action. Environ. Health Perspect. 60, 47-56.
35. Safe, S. H. (1994). Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit. Rev. Toxicol. 24, 87-149.
36. Salvi, M., and Toninello, A. (2001). Aroclor 1254 inhibits the mitochondrial permeability transition and release of cytochrome c: A possible mechanism for its in vivo toxicity. Toxicol. Appl. Pharmacol. 176, 92-100.
37. Schramm, H., Robertson, L. W., and Oesch, F. (1985). Differential regulation of hepatic glutathione transferase and glutathione peroxidase activities in the rat. Biochem. Pharmacol. 34, 3735-3759.
38. Sha, W. C., Liou, H. C., Tuomanen, E. I., and Baltimore, D. (1995). Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80, 321-330.
39. Silberhorn, E. M., Glauert, H. P., and Robertson, L. W. (1990). Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. Crit. Rev. Toxicol. 20, 440-496.
40. Snapper, C. M., Zelazowski, P., Rosas, F. R., Kehry, M. R., Tian, M., Baltimore, D., and Sha, W. C. (1996). B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156, 183-191.
41. Tamatani, M., Che, Y., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., Mizuno, T., and Tohyama, M. (1999). Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274, 8531-8538.
42. Tharappel, J. C., Lee, E. Y., Robertson, L. W., Spear, B. T., and Glauert, H. P. (2002). Regulation of cell proliferation, apoptosis, and transcription factor activities during the promotion of liver carcinogenesis by polychlorinated biphenyls. Toxicol. Appl. Pharmacol. 179, 172-184.
43. Tharappel, J. C., Nalca, A., Owens, A. B., Ghabrial, L., Konz, E. C., Glauert, H. P., and Spear, B. T. (2003). Cell proliferation and apoptosis are altered in mice deficient in the NF-kB p50 subunit after treatment with the peroxisome proliferator ciprofibrate. Toxicol. Sci. 75, 300-308.
44. Wang, C. Y., Guttridge, D. C., Mayo, M. W., and Baldwin, A. S. J. (1999). NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 19, 5923-5929.
45. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. (1998). NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
46. Wang, X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922-2933.
47. Whysner, J., and Wang, C. X. (2001). Hepatocellular iron accumulation and increased cell proliferation in polychlorinated biphenyl-exposed Sprague-Dawley rats and the development of hepatocarcinogenesis. Toxicol. Sci. 62, 36-45.